MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

MicroRNA Regulation of Epithelial to Mesenchymal Transition

(2016) Mohammed Abba et al.   Journal of Clinical Medicine

MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail

(2015) Q-F Zuo et al.   Cell Death & Disease

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

(2015) Yosuke Konno et al.   Oncotarget

Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention

(2014) Samantha Kaufhold et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Mir-34: A New Weapon Against Cancer?

(2014) Gabriella Misso et al.   Molecular Therapy-Nucleic Acids

Understanding and targeting cancer stem cells: therapeutic implications and challenges

(2013) Ke Chen et al.   ACTA PHARMACOLOGICA SINICA

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway

(2013) Yanfei Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines

(2013) Peixin Dong et al.   MOLECULAR CARCINOGENESIS

Multilayer control of the EMT master regulators

(2013) H Zheng et al.   ONCOGENE

Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer

(2012) Naofumi Kagara et al.   AMERICAN JOURNAL OF PATHOLOGY

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

(2012) Alexandria M Haslehurst et al.   BMC CANCER

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

(2012) Helge Siemens et al.   CELL CYCLE

Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis

(2012) Yan Wang et al.   EXPERIMENTAL CELL RESEARCH

Therapeutic strategies in epithelial ovarian cancer

(2012) Ayako Kim et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells

(2012) Li-Fang Zhu et al.   LABORATORY INVESTIGATION

Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

(2012) P Dong et al.   ONCOGENE

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer

(2011) Regalla Kumarswamy et al.   INTERNATIONAL JOURNAL OF CANCER

Ovarian Cancer Development and Metastasis

(2010) Ernst Lengyel   AMERICAN JOURNAL OF PATHOLOGY

The Promise of MicroRNA Replacement Therapy

(2010) A. G. Bader et al.   CANCER RESEARCH

miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells

(2010) Ming Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Epithelial–mesenchymal transition in ovarian cancer

(2009) Daniele Vergara et al.   CANCER LETTERS

MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes

(2009) Y. Li et al.   CANCER RESEARCH

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer

(2009) Elena Gallardo et al.   CARCINOGENESIS

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

(2009) Qing Ji et al.   PLoS One

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

(2008) Na Li et al.   CANCER LETTERS